Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical-stage biotechnology company, announced today that the first patient ...

Antioxidant-1 may promote HCC carcinogenesis through the activation of the c-Myb/PI3K/AKT pathway and the inhibition of copper accumulation and oxidative stress. Despite advancements in diagnostic and ...

Bottom Line: Researchers from Memorial Sloan Kettering Cancer Center (MSK) have identified, for the first time, an epigenetic mechanism promoting breast cancer. The team found that inhibition of the ...

Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...

Low-dose aspirin reduced colorectal cancer (CRC) recurrence rates by more than half in patients with tumors harboring mutations in the PI3K signaling pathway, according to findings from the phase 3 ...

A groundbreaking study reveals that a daily low dose of aspirin can significantly reduce the risk of colorectal cancer ...

Small molecules that spur cells to degrade a key growth-driving protein could offer a new tactic to combat tumors In the age of precision medicine, targeted drugs are transforming cancer treatment.